Beyond immune recovery: Quality of life and psychosocial challenges in children with inborn errors of immunity after transplantation
Authors:
- Sezin AydemirSASezin Aydemir
- Ekin NurhanENEkin Nurhan
- Isilay TuranITIsilay Turan
- Necmiye Keser OzturkNONecmiye Keser Ozturk
- Betul Gemici KaraaslanBKBetul Gemici Karaaslan
- Zeynep MericZMZeynep Meric
- Selami UlasSUSelami Ulas
- Sevgi Bilgic EltanSESevgi Bilgic Eltan
- Haluk Cezmi CokuğrasHCHaluk Cezmi Cokuğras
- Elif Karakoç AydınerEAElif Karakoç Aydıner
- Safa BarisSBSafa Baris
- Ahmet OzenAOAhmet Ozen
Open Access
- 13 June 2026
- journal article
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 195 (5) , 2923-2930
Abstract
Introduction: Hematopoietic stem cell transplantation (HSCT) provides definitive treatment for many inborn errors of immunity (IEI). Although most children achieve full immune reconstitution, long-term psychosocial and quality-of-life outcomes in medically stable survivors remain insufficiently understood. Methods: Children aged 8–18 years with IEI who achieved complete immune recovery and had no chronic complications were included. Quality of life and psychological status were evaluated using the Pediatric Quality of Life Inventory (PedsQL-C) and the Revised Children’s Anxiety and Depression Scale (RCADS). Healthy children matched for age, sex, and sociodemographic background served as controls. Results: Thirty-six patients and 41 controls participated. Children post-HSCT had significantly lower physical, psychosocial, and total quality-of-life scores (p = 0.022, 0.015, 0.006) and higher depression scores (p = 0.027). One-quarter of school-aged patients were not attending school, and one-third of families restricted exposure to crowded environments. Conclusion: Despite immune recovery, children remain vulnerable to psychosocial challenges. These findings support incorporation of routine psychological assessment and family counseling into long-term post-HSCT follow‑up.Keywords
Funding Information
- Istanbul University Cerrahpaşa
This publication has 25 references indexed in Scilit:
- The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of ImmunityJournal of Clinical Immunology, 2022
- Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of ImmunityJournal of Clinical Immunology, 2022
- Recommendations for Screening and Management of Late Effects in Patients with Severe Combined Immunodeficiency after Allogenic Hematopoietic Cell Transplantation: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCTTransplantation and Cellular Therapy, 2017
- Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiencyJournal of Allergy and Clinical Immunology, 2014
- Long-Term Survival and Late Deaths after Hematopoietic Cell Transplantation for Primary Immunodeficiency Diseases and Inborn Errors of MetabolismTransplantation and Cellular Therapy, 2012
- Health Related Quality of Life and Emotional Health in Children with Chronic Granulomatous Disease: A Comparison of Those Managed Conservatively with Those That Have Undergone Haematopoietic Stem Cell TransplantJournal of Clinical Immunology, 2012
- Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAbJournal of Allergy and Clinical Immunology, 2008
- Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiencyJournal of Allergy and Clinical Immunology, 2007
- Recovery and Long-term Function After Hematopoietic Cell Transplantation for Leukemia or LymphomaJAMA, 2004
- Quality of life of 125 adults surviving 6–18 years after bone marrow transplantationSocial Science & Medicine, 1995